Bittium Corporation’s Financial Calendar for 2021
Stock exchange release
Bittium Corporation's Financial Calendar for 2021
Bittium Corporation will publish financial reports from the first half of the year (Half Year Financial Report) and from the whole fiscal year (Financial Statement Bulletin). In addition, the company will publish Business Reviews from the financial periods of January-March and January-September. The structure of the Business Reviews is lighter than that of the financial reports.
In 2021, Bittium Corporation will publish its Half Year Financial Report and Financial Statement Bulletin as follows:
- Financial Statement Bulletin 2020: on February 11, 2021, at 8.00 am (CET+1)
- Half Year Financial Report January – June 2021: on August 6, 2021, at 8.00 am (CEST+1)
In 2021, Bittium Corporation will publish its Business Reviews as follows:
- Business Review January-March 2021: on April 29, 2021 at 8.00 am (CEST+1)
- Business Review January-September 2021: on October 22, 2021 at 8.00 am (CEST+1)
Bittium Corporation observes a three week silent period prior to announcing its financial reports. In 2021 the silent periods are as follows:
- January 21 - February 11, 2021
- April 8 – April 29, 2021
- July 16 – August 6, 2021
- October 1 – October 22, 2021
Bittium will release its Annual Report 2020 including Corporate Governance and Sustainability Report on March 24, 2021.
The Annual General Meeting will be held in Oulu, Finland on April 14, 2021 at 1.00 pm (CEST+1).
Oulu, December 15, 2020
Vice President, Communications and Marketing
Tel. +358 40 344 2789
Nasdaq Helsinki Oy
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2019 were EUR 75.2 million and operating profit was EUR 6.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com